Expertises
Medicine and Dentistry
- Breast Cancer
- Patient
- Therapeutic Procedure
- Recurrent Disease
- Mastectomy
- Overall Survival
- Cancer Registry
- Breast
Organisaties
Publicaties
2026
Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy DecisionāMaking in Dutch Breast Cancer Patients: A PopulationāBased Study (2026)International journal of cancer (E-pub ahead of print/First online). Meijer, J., Hermanns, N., Bijlsma, R., Blommestein, H. M., van den Bongard, D. H. J. G., van Dalen, T., van Diest, P. J., Drukker, C. A., Guerrero Paez, C., Honkoop, A. H., Jager, A., Koppert, L. B., Linn, S. C., van Maaren, M. C., Siemerink, E. J., van ’t Veer, L. J., Volders, J. H., Vrancken Peeters, M. J. & Siesling, S.https://doi.org/10.1002/ijc.70571Comparative validation of PREDICT versions 3.1 and 2.2 for overall survival in the Dutch breast cancer population (2026)The Breast, 85. Article 104681. Vreven, L. W. A., Verheul, E. M., van Maaren, M. C., Doornkamp, F., Schipper, R.-J., Siesling, S., Pharoah, P. D. P., Tjan-Heijnen, V. C. G. & Voogd, A. C.https://doi.org/10.1016/j.breast.2025.104681Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: A population-based study including 121347 patients (2026)The Breast, 85. Article 104673. Meijer, J., van den Bongard, H. J. G. D., Koppert, L. B., Menke-van der Houven van Oordt, C. W., de Munck, L., van Nijnatten, T. J. A., van der Sangen, M. J. C., Schipper, R. J., Schmidt, M. K., Smidt, M. L., Vreuls, W., van Maaren, M. C. & Siesling, S.https://doi.org/10.1016/j.breast.2025.104673
2025
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials (2025)npj Breast Cancer, 11(1). Article 116. Potter, S., Avery, K., Ahmed, R., de Boniface, J., Chatterjee, S., Dodwell, D., Dubsky, P., Federmann, J., Finestone, S., Gnant, M., Hlauschek, D., Iwata, H., Jiang, M. Y., Kaidar-Person, O., Lee, H.-B., MacKenzie, M., Meyn, A., Poortmans, P., Poulakaki, F., ⦠Corsi, F.https://doi.org/10.1038/s41523-025-00824-wImplementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020ā2023, using registry data and questionnaires (2025)Radiation Oncology, 20(1). Article 99. Eijkelboom, A. H., van Beek, E. J. A., Stam, M. R., Westhoff, P., van Maaren, M. C., Sattler, M. G. A., Bantema-Joppe, E. J., Verheij, M., van den Bongard, D. H. J. G. & Siesling, S.https://doi.org/10.1186/s13014-025-02669-wTrends in Surgical Treatment for cT4 Breast Cancer After Neoadjuvant Systemic Therapy: A Nationwide Study in The Netherlands (2025)Annals of surgical oncology, 32(12), 8668-8677. Jansen, B. A. M., Kelder, J. C., Borchert, T., van Uden, D. J. P., van der Leij, F., Schröder, C., Doeksen, A., Siesling, S., van Maaren, M. C. & Postma, E. L.https://doi.org/10.1245/s10434-025-17585-2Trends in use of magnetic resonance imaging and partial breast irradiation between 2011ā2022 in the Netherlands: A population-based study (2025)Clinical and Translational Radiation Oncology, 55. Article 101039. Civil, Y. A., Eijkelboom, A. H., Veldink, A. E., van Maarenc, M. C., Maduro, J. H., Duvivier, K. M., Siesling, S. & van den Bongard, H. J. G. D.https://doi.org/10.1016/j.ctro.2025.101039A Goal Without a Plan Is Just a Wish: Creating a Personalized Aftercare Plan for Breast Cancer Patients Supported by the Breast Cancer Aftercare Decision Aid (2025)Current Oncology, 32(10). Article 552. Dekker-Klaassen, A., Drossaert, C. H. C., Thé, R., Zeillemaker, A. M., van Hezewijk, M., De Keulenaar-Suiker, I. M., Knottnerus, B. J., Honkoop, A., van der Lee, M. L., Korevaar, J. C., Siesling, S. & van Maaren, M. C.https://doi.org/10.3390/curroncol32100552Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk Analysis (2025)Statistics in medicine, 44(18-19). Article e70066. van Hage, P., le Cessie, S., van Maaren, M. C., Putter, H. & van Geloven, N.https://doi.org/10.1002/sim.70066Five Year Conditional Relative Survival up to 10 Years Postdiagnosis among Adolescent and Young Adult Breast Cancer Patients by Age, Stage, and Receptor Subtype (2025)Journal of Young Women’s Breast Cancer and Health, 2(2), 67-68. Vrancken Peeters, N. J. M. C., van der Meer, D. J., Kok, M., van Maaren, M. C., Vrancken Peeters, M. J. T. F. D., Siesling, S., van der Graaf, W. T. A. & Husson, O.https://doi.org/10.4103/YWBC.YWBC_2_25
Onderzoeksprofielen
Vakken collegejaar 2026/2027
Vakken in het huidig collegejaar worden toegevoegd op het moment dat zij definitief zijn in het Osiris systeem. Daarom kan het zijn dat de lijst nog niet compleet is voor het gehele collegejaar.
Vakken collegejaar 2025/2026
Vakken collegejaar 2024/2025
Adres

Universiteit Twente
Technohal (gebouwnr. 18), kamer 3304
Hallenweg 5
7522 NH Enschede
Universiteit Twente
Technohal 3304
Postbus 217
7500 AE Enschede